Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938
administrator
Drug Test
  • February 21, 2025

Development of a method to evaluate the effects of external environments on drug stability in nails using micro‐segmental analysis

An evaluation method using micro-segmental analysis (MSA) of a single nail was developed to examine the effects of external environments…
Drug Test
  • February 21, 2025

Development of 3β,4α‐dihydroxy‐5α‐androstan‐17‐one standard solution for doping analyses

In this work, a certified reference material (CRM) for 3β,4α-dihydroxy-5α-androstan-17-one (DHAS), a metabolite of formestane that is used to conceal…
Drug Test
  • February 21, 2025

Advances in SARMs anti‐doping analysis

The current development in liquid chromatography–tandem mass spectrometry methods provides an efficient solution for analysing traditional (urine, serum, plasma), as…
kedake-inc-issues-allergy-alert-on-undeclared-sesame,-soy,-wheat,-yellow-no-5,-yellow-no-6,-and-red-no.-6-in-botana-mix-snacks FDA
  • February 20, 2025

Kedake Inc. Issues Allergy Alert on Undeclared Sesame, Soy, Wheat, Yellow No. 5, Yellow No. 6, and Red No. 6 in Botana Mix Snacks

KEDAKE, INC. of Houston, TX is recalling it’s 2 lb packages of Las Ollas Botana Mix Snacks because they may…
compounding:-inspections,-recalls,-and-other-actions Drug Test
  • February 20, 2025

Compounding: Inspections, Recalls, and other Actions

Human drug compounding; FDA inspections; compounding recalls
safety-clinical-trial-shows-possible-increased-risk-of-cancer-with-weight-loss-medicine-belviq,-belviq-xr-(lorcaserin) Drug Test
  • February 20, 2025

Safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin)

A safety clinical trial shows a possible increased risk of cancer with the weight-loss drug Belviq, Belviq XR. Consider the…
fda-strengthens-warning-that-untreated-constipation-caused-by-schizophrenia-medicine-clozapine-(clozaril)-can-lead-to-serious-bowel-problems Drug Test
  • February 20, 2025

FDA strengthens warning that untreated constipation caused by schizophrenia medicine clozapine (Clozaril) can lead to serious bowel problems

FDA warns that untreated constipation caused by schizophrenia drug clozapine (Clozaril) can get worse and lead to serious bowel problems…
fda-requests-the-withdrawal-of-the-weight-loss-drug-belviq,-belviq-xr-(lorcaserin)-from-the-market Drug Test
  • February 20, 2025

FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market

FDA has requested that the weight-loss drug Belviq, Belviq XR be withdrawn from the U.S. market because a safety clinical…
is-cross-border-e-commerce-air-cargo-demand-at-risk? Medical Supplies
  • February 20, 2025

Is cross-border e-commerce air cargo demand at risk?

The looming demise of the de minimis exemption could spur higher costs and delays, said Xeneta’s Niall van de Wouw.
fda-requires-boxed-warning-about-serious-mental-health-side-effects-for-asthma-and-allergy-drug-montelukast-(singulair);-advises-restricting-use-for-allergic-rhinitis Drug Test
  • February 20, 2025

FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis

FDA requires a Boxed Warning about serious mental health side effects for the asthma & allergy drug Singulair (montelukast). Only…